Sloan-Kettering, Hartford HealthCare Form Partnership
Memorial Sloan-Kettering Cancer Center, New York, has selected Hartford HealthCare, a multi-hospital health care system in Connecticut, as a pioneering member of the newly formed Memorial Sloan-Kettering Cancer Alliance.
Memorial Sloan-Kettering Cancer Center, New York, has selected Hartford HealthCare, a multi-hospital health care system in Connecticut, as a pioneering member of the newly formed Memorial Sloan-Kettering Cancer Alliance.
The joint announcement, made in Hartford by leaders of the two organizations, comes after year-long discussions: The partners say the result is "a distinctive clinical and research partnership built to rapidly move innovative, evidence-based cancer care into the community setting and enable bi-directional learning across the institutions."
Over the next six months, teams from MSK and the Hartford HealthCare Cancer Institute will work collaboratively to assess the resources and capabilities of each of the system’s five acute care hospitals, identifying specific areas of focus. In addition, they will jointly recruit a physician-in-chief of the Hartford HealthCare Cancer Institute who will be on the staff at both Hartford HealthCare and Memorial Sloan-Kettering. The two organizations will work over the next few months to integrate Hartford physicians into MSK’s disease management teams.
The partners also say they will collaborate on disease management teams, through on-site observations of new techniques, by sharing educational resources, by conducting quality and outcomes research, and by working together toward expanded access to MSK’s clinical trials.
"MSK and HHC will work collaboratively to measure changes in outcomes including survival rates, quality of life, and total cost of care," the organizations said in a prepared statement announcing the agreement. "HHC and future Alliance members will provide MSK with first-hand knowledge of how cancer advances are practiced in a community setting, where more than 80 percent of cancer patients in the United States receive cancer care."
The joint announcement, made in Hartford by leaders of the two organizations, comes after year-long discussions: The partners say the result is "a distinctive clinical and research partnership built to rapidly move innovative, evidence-based cancer care into the community setting and enable bi-directional learning across the institutions."
Over the next six months, teams from MSK and the Hartford HealthCare Cancer Institute will work collaboratively to assess the resources and capabilities of each of the system’s five acute care hospitals, identifying specific areas of focus. In addition, they will jointly recruit a physician-in-chief of the Hartford HealthCare Cancer Institute who will be on the staff at both Hartford HealthCare and Memorial Sloan-Kettering. The two organizations will work over the next few months to integrate Hartford physicians into MSK’s disease management teams.
The partners also say they will collaborate on disease management teams, through on-site observations of new techniques, by sharing educational resources, by conducting quality and outcomes research, and by working together toward expanded access to MSK’s clinical trials.
"MSK and HHC will work collaboratively to measure changes in outcomes including survival rates, quality of life, and total cost of care," the organizations said in a prepared statement announcing the agreement. "HHC and future Alliance members will provide MSK with first-hand knowledge of how cancer advances are practiced in a community setting, where more than 80 percent of cancer patients in the United States receive cancer care."
More for you
Loading data for hdm_tax_topic #better-outcomes...